175 related articles for article (PubMed ID: 38330710)
1. The effect of lipid metabolism on cuproptosis-inducing cancer therapy.
Zhong Y; Zeng W; Chen Y; Zhu X
Biomed Pharmacother; 2024 Mar; 172():116247. PubMed ID: 38330710
[TBL] [Abstract][Full Text] [Related]
2. Copper homeostasis and cuproptosis in cancer immunity and therapy.
Liu WQ; Lin WR; Yan L; Xu WH; Yang J
Immunol Rev; 2024 Jan; 321(1):211-227. PubMed ID: 37715546
[TBL] [Abstract][Full Text] [Related]
3. Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases.
Han J; Luo J; Wang C; Kapilevich L; Zhang XA
Biomed Pharmacother; 2024 May; 174():116570. PubMed ID: 38599063
[TBL] [Abstract][Full Text] [Related]
4. Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance.
Wang Y; Chen Y; Zhang J; Yang Y; Fleishman JS; Wang Y; Wang J; Chen J; Li Y; Wang H
Drug Resist Updat; 2024 Jan; 72():101018. PubMed ID: 37979442
[TBL] [Abstract][Full Text] [Related]
5. Copper Deposition in Polydopamine Nanostructure to Promote Cuproptosis by Catalytically Inhibiting Copper Exporters of Tumor Cells for Cancer Immunotherapy.
Chang J; Yin W; Zhi H; Chen S; Sun J; Zhao Y; Huang L; Xue L; Zhang X; Zhang T; Dong H; Li Y
Small; 2024 Feb; ():e2308565. PubMed ID: 38339770
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application.
Liu N; Chen M
Biomed Pharmacother; 2024 Feb; 171():116115. PubMed ID: 38181713
[TBL] [Abstract][Full Text] [Related]
7. Copper homeostasis and cuproptosis in mitochondria.
Tian Z; Jiang S; Zhou J; Zhang W
Life Sci; 2023 Dec; 334():122223. PubMed ID: 38084674
[TBL] [Abstract][Full Text] [Related]
8. Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies.
Bian C; Zheng Z; Su J; Chang S; Yu H; Bao J; Xin Y; Jiang X
Front Pharmacol; 2023; 14():1271613. PubMed ID: 37767404
[TBL] [Abstract][Full Text] [Related]
9. Cuproptosis in cancers: Function and implications from bench to bedside.
Huang XY; Shen JY; Huang K; Wang L; Sethi G; Ma Z
Biomed Pharmacother; 2024 Jun; 176():116874. PubMed ID: 38850661
[TBL] [Abstract][Full Text] [Related]
10. Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy.
Zheng P; Zhou C; Lu L; Liu B; Ding Y
J Exp Clin Cancer Res; 2022 Sep; 41(1):271. PubMed ID: 36089608
[TBL] [Abstract][Full Text] [Related]
11. Copper homeostasis and cuproptosis in atherosclerosis: metabolism, mechanisms and potential therapeutic strategies.
Yang S; Li Y; Zhou L; Wang X; Liu L; Wu M
Cell Death Discov; 2024 Jan; 10(1):25. PubMed ID: 38218941
[TBL] [Abstract][Full Text] [Related]
12. Cuproptosis: Harnessing Transition Metal for Cancer Therapy.
Wang W; Mo W; Hang Z; Huang Y; Yi H; Sun Z; Lei A
ACS Nano; 2023 Oct; 17(20):19581-19599. PubMed ID: 37820312
[TBL] [Abstract][Full Text] [Related]
13. Copper Homeostasis Based on Cuproptosis-Related Signature Optimizes Molecular Subtyping and Treatment of Glioma.
Zhang S; Yu H; Sun S; Fan X; Bi W; Li S; Wang W; Fang Z; Chen X
Mol Neurobiol; 2023 Dec; ():. PubMed ID: 38151613
[TBL] [Abstract][Full Text] [Related]
14. Cuproptosis, the novel therapeutic mechanism for heart failure: a narrative review.
Yuan HJ; Xue YT; Liu Y
Cardiovasc Diagn Ther; 2022 Oct; 12(5):681-692. PubMed ID: 36329965
[TBL] [Abstract][Full Text] [Related]
15. Cuproptosis and cuproptosis-related genes: Emerging potential therapeutic targets in breast cancer.
Liu X; Luo B; Wu X; Tang Z
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189013. PubMed ID: 37918452
[TBL] [Abstract][Full Text] [Related]
16. Cuproptosis: emerging biomarkers and potential therapeutics in cancers.
Wang M; Zheng L; Ma S; Lin R; Li J; Yang S
Front Oncol; 2023; 13():1288504. PubMed ID: 38023234
[TBL] [Abstract][Full Text] [Related]
17. Research progress in cuproptosis in liver cancer.
Chen L; Liu D; Tan Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Sept 28; 48(9):1368-1376. PubMed ID: 38044648
[TBL] [Abstract][Full Text] [Related]
18. Cuproptosis-a potential target for the treatment of osteoporosis.
Li D; Gao Z; Li Q; Liu X; Liu H
Front Endocrinol (Lausanne); 2023; 14():1135181. PubMed ID: 37214253
[TBL] [Abstract][Full Text] [Related]
19. Cuproptosis: Mechanism, role, and advances in urological malignancies.
Wu J; He J; Liu Z; Zhu X; Li Z; Chen A; Lu J
Med Res Rev; 2024 Jul; 44(4):1662-1682. PubMed ID: 38299968
[TBL] [Abstract][Full Text] [Related]
20. Regulatory roles of copper metabolism and cuproptosis in human cancers.
Wang Z; Jin D; Zhou S; Dong N; Ji Y; An P; Wang J; Luo Y; Luo J
Front Oncol; 2023; 13():1123420. PubMed ID: 37035162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
